Browse By: Country ι Category ι Tag

Biosimilar Market Research Reports

Biosimilars And Biosuperiors Therapeutics Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
A biosimilar medicine possesses the similar pharmacokinetic and mode of action as an original biological medicine that has already been approved for therapeutic use. Biosimilars are made from a living organism such as bacteria and yeast or can also be derived from small molecules like human insulin, erythropoietin and monoclonal antibodies via recombinant DNA and gene expression technologies. Biosimilars are developed only when original biological medicines are commercially expired and therefore are known as follow on biologics or subsequent entry biologics. These molecules are used to treat same diseases as original molecules intended to. Like biosimilars, biosuperiors are also developed against already approved biological medicines but they possess attributes that are superior to the ori
Published Date: Jul 2024
Published By: Transparency

Price: $5795
United States Biosimilar Insulin Market Report 2017
Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Biosimilar Insulin in these regions, from 2012 to 2022 (forecast). United States Biosimilar Insulin market competition by top manufacturers/players, with Biosimilar Insulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Biogenomics Eli Lilly Gan&Lee Pharmaceuticals Geropharm Julphar Gulf Pharmaceutical Industries Paras Biopharmaceuticals Samsung Bioepis Sedico Wockhardt Teva Pharmaceuticals On the basis of product, this repor
Published Date: Apr 2017
Published By: QYResearch

Price: $3800
Global Biosimilar Insulin Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Biosimilar Insulin for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Biosimilar Insulin market competition by top manufacturers/players, with Biosimilar Insulin sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Biogenomics Eli Lilly Gan&Lee Pharmaceuticals Geropharm Julphar Gulf Pharmaceutical Industries Paras Biopharmaceuticals Samsung Bioepis Sedico Wockhardt Teva Pharmaceuticals On the basis of product, this report displays the
Published Date: Mar 2017
Published By: QYResearch

Price: $4000
Global Biosimilar Insulin Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilar Insulin in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Biosimilar Insulin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Pfizer Biogenomics Eli Lilly Gan&Lee Pharmaceuticals Geropharm Julphar Gulf Pharmaceutical Industries Paras Biopharmaceuticals Samsung Bioepis Sedico Wockhardt Teva Pharmaceuticals On the basis of product, this report displays the production, revenue, price, market share and
Published Date: Mar 2017
Published By: QYResearch

Price: $2900
Global and Chinese Biologics and Biosimilars Industry, 2017 Market Research Report
Published Date: Mar 2017
Published By: Prof Research

Price: $3000
Global and Chinese Biosimilar Drug Industry, 2017 Market Research Report
Published Date: Mar 2017
Published By: Prof Research

Price: $3000
China Biosimilar Monoclonal Antibodies Market Research Report 2017
Sales, means the sales volume of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies Biosimilar Monoclonal Antibodies in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Celltrion Boehringer Ingelheim Dr Reddy’s Sandoz Zydus Samsung Amgen Hospira Shanghai CP Guojian Pharmaceutical Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Ty
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Global Biosimilar Drug Industry Situation and Prospects Research report
The Global Biosimilar Drug Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Biosimilar Drug industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand by 2.7 per cent in 2017 and 2.9 per cent in 2018, with this modest recovery more an indication of economic stabilization than a signal of a robust and sustained revival of global demand. Given the close linkages between demand, investment, trade and productivity, the extended episode of weak global
Published Date: Mar 2017
Published By: Stanley Consulting Company (SCC)

Price: $2850
China Biosimilars Market Research Report 2017
Sales, means the sales volume of Biosimilars Revenue, means the sales value of Biosimilars This report studies Biosimilars in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Sandoz International Hospira Teva Pharmaceutical Dr. Reddy’s Laboratories Biocon Mylan Amgen Celltrion Roche Diagnostics Merck KGaA Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by Application, this report
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Europe Biosimilar Monoclonal Antibodies Market Report 2017
Sales, means the sales volume of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Celltrion Boehringer Ingelheim Dr Reddy’s Sandoz Zydus Samsung Amgen Hospira Shanghai CP Guojian Pharmaceutical Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these countries, from 2011 to 202
Published Date: Mar 2017
Published By: QYResearch

Price: $3900
Europe Biosimilars Market Report 2017
Sales, means the sales volume of Biosimilars Revenue, means the sales value of Biosimilars This report studies sales (consumption) of Biosimilars in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Sandoz International Hospira Teva Pharmaceutical Dr. Reddy’s Laboratories Biocon Mylan Amgen Celltrion Roche Diagnostics Merck KGaA Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilars in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia
Published Date: Mar 2017
Published By: QYResearch

Price: $3900
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design
GBI Research’s latest report, ""Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design"" provides an in-depth assessment of the current trends in the global biosimilars market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics that include data split by therapy area, stage of development, molecular target, clinical trials and company. 
Published Date: Mar 2017
Published By: GBI Research

Price: $2995
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. 
Published Date: Mar 2017
Published By: GBI Research

Price: $4995
United States Biosimilar Monoclonal Antibodies Market Report 2017
Sales, means the sales volume of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Celltrion Boehringer Ingelheim Dr Reddy’s Sandoz Zydus Samsung Amgen Hospira Shanghai CP Guojian Pharmaceutical Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by applications, this report focuses on sales, market share and growth ra
Published Date: Mar 2017
Published By: QYResearch

Price: $3800
China Remicade Biosimilar Market Research Report 2017
Sales, means the sales volume of Remicade Biosimilar Revenue, means the sales value of Remicade Biosimilar This report studies Remicade Biosimilar in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Teva Pharmaceutical Industries Synthon Pharmaceuticals LG Life Sciences Novartis (Sandoz) Celltrion Biocon Hospira Merck Serono (Merck Group) Biogen idec Inc. Genentech (Roche Group) Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share and growth rate of each type, can
Published Date: Feb 2017
Published By: QYResearch

Price: $3200
United States Biosimilars Market Report 2017
Sales, means the sales volume of Biosimilars Revenue, means the sales value of Biosimilars This report studies sales (consumption) of Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Sandoz International Hospira Teva Pharmaceutical Dr. Reddy’s Laboratories Biocon Mylan Amgen Celltrion Roche Diagnostics Merck KGaA Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application,
Published Date: Feb 2017
Published By: QYResearch

Price: $3800
Global Biosimilar Monoclonal Antibodies Sales Market Report 2017
Sales, means the sales volume of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Celltrion Boehringer Ingelheim Dr Reddy’s Sandoz Zydus Samsung Amgen Hospira Shanghai CP Guojian Pharmaceutical Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these regions, from 2011 to 2021 (forecast), l
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Europe Remicade Biosimilar Market Report 2017
Sales, means the sales volume of Remicade Biosimilar Revenue, means the sales value of Remicade Biosimilar This report studies sales (consumption) of Remicade Biosimilar in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Teva Pharmaceutical Industries Synthon Pharmaceuticals LG Life Sciences Novartis (Sandoz) Celltrion Biocon Hospira Merck Serono (Merck Group) Biogen idec Inc. Genentech (Roche Group) Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Remicade Biosimilar in these countr
Published Date: Feb 2017
Published By: QYResearch

Price: $3900
Global Biosimilars Sales Market Report 2017
Sales, means the sales volume of Biosimilars Revenue, means the sales value of Biosimilars This report studies sales (consumption) of Biosimilars in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Sandoz International Hospira Teva Pharmaceutical Dr. Reddy’s Laboratories Biocon Mylan Amgen Celltrion Roche Diagnostics Merck KGaA Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilars in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Sou
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Global Biosimilar Monoclonal Antibodies Market Research Report 2017
Production, means the output of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies Biosimilar Monoclonal Antibodies in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Celltrion Boehringer Ingelheim Dr Reddy’s Sandoz Zydus Samsung Amgen Hospira Shanghai CP Guojian Pharmaceutical Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these regions, from 2011 to 2021 (forecast),
Published Date: Feb 2017
Published By: QYResearch

Price: $2900

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top